Prosthetic Heart Valve Market - Global Industry Analysis, Growth, Trends and Forecast to 2024

Prosthetic Heart Valve Market - Global
Industry Insights, Trends, Outlook, and
Opportunity Analysis, 2016-2024
[DATE]
[COMPANY NAME]
[Company address]
Report Description
Prosthetic Heart Valve Market Overview
Prosthetic (artificial) heart valve refers to a device implanted in the heart of a patient suffering from valvular
heart disease. A cardiac surgery is performed to replace the abnormal heart valve with a prosthetic heart
valve. Replacement of a diseased valve with a prosthetic heart valve results in reduction in morbidity and
mortality associated with the cardiac valve disorder. When the treatment of heart valve disease reaches
a stage where it does not provide relief to the patient, then surgery recommended as the best alternative
to repair or replace the valve. In case of a valve replacement surgery, carbon based mechanical valves
and biological tissue valve are the types of valves that can be selected based on the condition.
Advancements in technology and increasing prevalence of heart valve diseases are some major factors
projected to drive growth of the prosthetic heart valve market in the near future.
Get FREE Sample Of This Research Report At :
https://www.coherentmarketinsights.com/insight/request-sample/69
Selection of a Heart Valve also depends on the Type of Polymer
On the basis of product type, the global prosthetic heart valve market can be segmented into mechanical
heart valves, transcatheter heart valves, and tissue heart valves. Tissue heart valves are harvested from
pig heart valves and cow heart sac. The life of a tissue valve is 10 to 15 years. Tissue heart valves is
further classified into stented tissue valve, stentless tissue valve, tissue-engineered valves, homograft
valves, and heterograft valves. Aortic valves and mechanical mitral valves are the two types of mechanical
heart valves.
Technologies for prosthetic heart valves include anti-calcification, sutureless valves, polymers, and
carbon-based technologies. The primary cause of failure of bioprosthetic valves is structural valve
deterioration due to tissue calcification. An anticalcification technology was developed that may
irreversibly choke calcium binding sites in bioprosthetic valves. In February 2016, the U.S. FDA approved
a new technology called sutureless aortic valve replacement that is used for treatment of aortic valve
disease. Sutureless valves are used to treat aortic valve disease and is a relatively less invasive for
patients. The use of polymers to produce leaflet valves, which have same benefit of bioprosthetic and
mechanical valves has been available since mid-1950s. Much attention has been focused on
thermoplastic polyurethanes due to its various beneficial properties.
Browse The Full Research Report At : https://www.coherentmarketinsights.com/ongoinginsight/prosthetic-heart-valve-market-69
Developed Nations Current Hubs, while Low and Middle Income Countries to emerge as Major
Markets
Increasing prevalence of heart diseases, technological advancements, government funding, robust
healthcare infrastructure, and rise in healthcare expenditure in the U.S. are major factors projected to
propel growth of the prosthetic heart valve market in this region. According to Centers for Diseases Control
and Prevention (CDC) about 610,000 people die due to heart diseases in U.S. every year. The growth of
prosthetic heart valve market in Asia is expected to be high in the near future due to increasing incidence
of various chronic diseases and improving healthcare infrastructure in this region. According to a study
published in the Lancet—a U.K.-based medical journal—the number of people affected by high blood
pressure has almost doubled over past 40 years (from 1975 to 2015).
Growing Aging Population highly susceptible to Heart Diseases to Spur growth of the prosthetic
heart valve market
Advancements in technology, increasing aging population, and significant rise in prevalence of heart valve
disorder are some factors that are expected to drive growth of the prosthetic heart valve market in the
near future. However, factors such as high costs of development, stringent government regulations,
reimbursement issues, and lack of trained professionals are inhibiting growth of the prosthetic heart valve
market to certain extent.
Global players involved in the prosthetic heart valve market
The prosthetic heart valve market is characterized by the presence of major global players. Some of the
prominent names include Boston Scientific Corporation, St. Jude Medical, Inc., Sorin S.P.A, Abbott
Laboratories, Claret Medical, Inc., AorTech, Edwards Lifesciences Corporation, Neovasc Inc., and
JenaValve Technology.
Request For Customization : https://www.coherentmarketinsights.com/insight/requestdiscount/69
Better Patient Outcomes utilizing Prosthetic Heart Valves to Ensure Sustained Demand
Developed regions such as North America and Europe are rapidly growing regions in the prosthetic heart
valve market, mainly attributed to robust healthcare infrastructure, increasing prevalence of valvular heart
disease, and favorable reimbursement scenario. The experience of using an aortic bioprosthetic valve
treated with anticalcification tissue technology demonstrates excellent valve performance, safety, and
durability. Minimally invasive devices for treatment of heart surgery are the need of the hour to ensure
better patient experience. The sutureless valve technology is less invasive for patients, which is expected
to witness higher adoption in the near future. Transcatheter has given improved patient survival rate when
compared with medical therapy.
Request Discount : https://www.coherentmarketinsights.com/insight/request-discount/69
About Us
COMPANY OVERVIEW
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting
our plethora of clients achieve transformational growth by helping them make critical business decisions.
We are headquartered in India, having office at global financial capital in the U.S. Our client base includes
players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to
help businesses around the globe deliver practical and lasting results through various recommendations
about operational improvements, technologies, emerging market trends and new working methods. We
offer both customized and syndicated market research reports that help our clients create visionary growth
plans to provide traction to their business. We meticulously study emerging trends across various
industries at both the global and regional levels to identify new opportunities for our clientele. Our global
team of over 100 research analysts and freelance consultants provide market intelligence from the very
molecular country level and also provide a global perspective of the market. Our team is of the most vital
cog in our robust machinery that gives us the ability to deliver independent insight relying on our cognitive
defusion training module.This allows for an objective and unbiased assessment of the market. We pride
ourselves in my constantly striving to update our extremely in-depth understanding of the market by
closely monitoring and analyzing markets, trends, and emerging best practices, across allfathomable
industries under the sun. This enables us to equip our valued clientele with key decisive inputs to capitalize
on lucrative growth opportunities in the market and to follow firmly position themselves on a high growth
path in the future.
Contact Us
CONTACT US
CORPORATE OFFICE:
Raj Shah
Coherent Market Insights
1001 4th Ave,
# 3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]
Website: https://www.coherentmarketinsights.com/
Visit Blog : http://globalresearchtrends.blogspot.in/

Prosthetic (artificial) heart valve refers to a device implanted in the heart of a patient suffering from valvular heart disease. A cardiac surgery is performed to replace the abnormal heart valve with a prosthetic heart valve. Replacement of a diseased valve with a prosthetic heart valve results in reduction in morbidity and mortality associated with the cardiac valve disorder. When the treatment of heart valve disease reaches a stage where it does not provide relief to the patient, then surgery recommended as the best alternative to repair or replace the valve. In case of a valve replacement surgery, carbon based mechanical valves and biological tissue valve are the types of valves that can be selected based on the condition. Advancements in technology and increasing prevalence of heart valve diseases are some major factors projected to drive growth of the prosthetic heart valve market in the near future